Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 02-Nov-2022 titled Glenmark Pharmaceuticals receives ANDA approval for Sodium Phenylbutyrate Tablets USP, 500 mg……
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
